Gufic Biosciences Ltd
GUFICBIO
Company Profile
Business description
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.
Contact
SM House, 11 Sahakar Road
1st to 4th Floor
Vile Parle (East)
MumbaiMH400 057
INDT: +91 2267261000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
2,671
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,756.90 | 16.70 | -0.19% |
| CAC 40 | 7,557.31 | 0.85 | -0.01% |
| DAX 40 | 23,649.30 | 150.97 | 0.64% |
| Dow JONES (US) | 43,386.84 | 404.41 | 0.94% |
| FTSE 100 | 8,735.60 | 16.85 | 0.19% |
| HKSE | 24,217.55 | 107.85 | -0.44% |
| NASDAQ | 20,167.91 | 194.36 | 0.97% |
| Nikkei 225 | 40,105.02 | 520.44 | 1.31% |
| NZX 50 Index | 12,583.59 | 103.54 | 0.83% |
| S&P 500 | 6,141.02 | 48.86 | 0.80% |
| S&P/ASX 200 | 8,528.80 | 22.00 | -0.26% |
| SSE Composite Index | 3,427.08 | 21.38 | -0.62% |